Voss Capital’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-125,000
| Closed | -$446K | – | 51 |
|
2023
Q1 | $446K | Hold |
125,000
| – | – | 0.06% | 34 |
|
2022
Q4 | $356K | Sell |
125,000
-75,000
| -38% | -$214K | 0.07% | 38 |
|
2022
Q3 | $446K | Buy |
200,000
+100,000
| +100% | +$223K | 0.13% | 35 |
|
2022
Q2 | $249K | Buy |
+100,000
| New | +$249K | 0.08% | 34 |
|
2021
Q3 | – | Sell |
-125,000
| Closed | -$1.46M | – | 34 |
|
2021
Q2 | $1.46M | Buy |
125,000
+25,000
| +25% | +$291K | 0.61% | 28 |
|
2021
Q1 | $1.22M | Sell |
100,000
-120,714
| -55% | -$1.47M | 0.51% | 35 |
|
2020
Q4 | $2.76M | Sell |
220,714
-5,859
| -3% | -$73.3K | 1.39% | 25 |
|
2020
Q3 | $3.41M | Buy |
226,573
+183,773
| +429% | +$2.77M | 1.95% | 24 |
|
2020
Q2 | $1.05M | Sell |
42,800
-45,870
| -52% | -$1.12M | 0.7% | 28 |
|
2020
Q1 | $749K | Sell |
88,670
-3,830
| -4% | -$32.4K | 1% | 19 |
|
2019
Q4 | $1.47M | Buy |
+92,500
| New | +$1.47M | 0.22% | 21 |
|